Hinge Health, Inc.

Hinge Health, Inc. is a digital healthcare company specializing in musculoskeletal (MSK) care, offering virtual physical therapy and pain management solutions. Founded in 2014, its core mission is to treat and prevent joint and muscle pain, improve health outcomes for members, and reduce healthcare costs for its clients. The company's headquarters are located in San Francisco, California, at 455 Market Street, Suite 700.

Hinge Health provides a comprehensive platform that combines AI-powered motion tracking technology, personalized exercise programs, and access to a dedicated care team including licensed physical therapists and health coaches. Key offerings include virtual physical therapy for chronic MSK pain, acute injuries, and post-surgical rehabilitation, as well as wearable devices like the Enso device for pain relief. The company has expanded its services to address additional conditions such as migraine care and women's pelvic health. Hinge Health primarily serves employers, health plans, and pharmacy benefit managers, with over 2 million members and partnerships with more than 2,600 companies.

In a significant corporate development, Hinge Health completed its Initial Public Offering (IPO) on the New York Stock Exchange (NYSE) on May 21, 2025, trading under the ticker symbol HNGE and raising approximately $437.3 million. The company has demonstrated strong financial performance, boosting its full-year revenue outlook for 2026 after reporting a 47% year-over-year increase in first-quarter 2026 revenue. Recent innovations include the launch of new AI-powered care tools such as Movement Analysis and Robin, an AI Care Assistant. Leadership is spearheaded by Co-Founder and CEO Daniel Perez, with Gabriel Mecklenburg serving as Co-Founder and Executive Chairman.